Ligand · 351
351 · 1-(3-{5-[4-(aminomethyl)phenyl]-1H-pyrrolo[2,3-b]pyridin-3-yl}phenyl)-3-(2-phenoxyphenyl)urea
351, 1-(3-{5-[4-(aminomethyl)phenyl]-1H-pyrrolo[2,3-b]pyridin-3-yl}phenyl)-3-(2-phenoxyphenyl)urea (C33 H27 N5 O2, 525.6 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its residues…
- Component
- 351
- Formula
- C33 H27 N5 O2
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
351 in 2 structures; the first of them:
- 3ETA · Kinase domain of insulin receptor complexed with a pyrrolo pyridine inhibitor · 351 A2001 · binds LEU1002, GLY1003, VAL1010, ALA1028, LYS1030, GLU1047, VAL1050, MET1051 and 15 more
- 3ETA · Kinase domain of insulin receptor complexed with a pyrrolo pyridine inhibitor · 351 A2001 · binds LEU1002, GLY1003, VAL1010, ALA1028, LYS1030, GLU1047, VAL1050, MET1051 and 15 more
Residues it binds most
MET 4, VAL 4, GLY 4, LEU 4, PHE 4, GLU 4, ILE 4, ALA 4, ASP 4, HIS 4 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.